These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33245352)

  • 1. 30 Years on the Road to Hepatitis C Elimination.
    Thomas DL
    J Infect Dis; 2020 Nov; 222(Suppl 9):S739-S740. PubMed ID: 33245352
    [No Abstract]   [Full Text] [Related]  

  • 2. Global hepatitis C elimination: an investment framework.
    Pedrana A; Howell J; Scott N; Schroeder S; Kuschel C; Lazarus JV; Atun R; Baptista-Leite R; 't Hoen E; Hutchinson SJ; Aufegger L; Peck R; Sohn AH; Swan T; Thursz M; Lesi O; Sharma M; Thwaites J; Wilson DP; Hellard M
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):927-939. PubMed ID: 32730786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remaining challenges in HCV elimination.
    Capraru C; Feld JJ
    J Hepatol; 2021 Apr; 74(4):964-965. PubMed ID: 33589319
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C elimination: Tailoring the approach to each country's needs and realities.
    Kondili LA; Craxi A
    Hepatology; 2024 Aug; 80(2):263-265. PubMed ID: 38441956
    [No Abstract]   [Full Text] [Related]  

  • 5. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH).
    Crespo J; Albillos A; Buti M; Calleja JL; García Samaniego J; Hernández Guerra M; Serrano T; Turnes J; Acín E; Berenguer J; Berenguer M; Colom J; Fernández I; Fernández Rodríguez C; Forns X; García F; Grandados R; Lazarus JV; Molero JM; Molina E; Pérez Escanilla F; Pineda JA; Rodríguez M; Romero M; Roncero C; Saiz de la Hoya P; Sánchez Antolín G
    Rev Esp Enferm Dig; 2019 Nov; 111(11):862-873. PubMed ID: 31657609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.
    Akiyama MJ; Kronfli N; Cabezas J; Sheehan Y; Thurairajah PH; Lines R; Lloyd AR;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):391-400. PubMed ID: 33857445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The global elimination of hepatitis C?
    Sonderup MW
    S Afr Med J; 2018 Aug; 108(8b):31-34. PubMed ID: 30182910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phases of hepatitis C elimination: achieving WHO elimination targets.
    Pedrana A; Munari S; Stoové M; Doyle J; Hellard M
    Lancet Gastroenterol Hepatol; 2021 Jan; 6(1):6-8. PubMed ID: 33308435
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C: only a step away from elimination?
    Lancet; 2015 Mar; 385(9973):1045. PubMed ID: 25797543
    [No Abstract]   [Full Text] [Related]  

  • 10. Global elimination of hepatitis C virus by 2030: why not?
    Dore GJ; Martinello M; Alavi M; Grebely J
    Nat Med; 2020 Feb; 26(2):157-160. PubMed ID: 32047317
    [No Abstract]   [Full Text] [Related]  

  • 11. What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.
    Ward JW; Hinman AR
    Gastroenterology; 2019 Jan; 156(2):297-310. PubMed ID: 30391470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Second Biggest Infectious Disease Killer in the U.S.: Hepatitis C Virus Infection and Steps Towards its Elimination in Rhode Island and Beyond.
    Taylor LE
    R I Med J (2013); 2020 Jun; 103(5):19-21. PubMed ID: 32481774
    [No Abstract]   [Full Text] [Related]  

  • 13. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
    Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
    Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
    World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-Care Testing for Hepatitis C Infection: A Critical Building Block for the Foundation to Achieve Elimination.
    Grebely J
    Clin Infect Dis; 2024 Oct; 79(4):974-977. PubMed ID: 38513081
    [No Abstract]   [Full Text] [Related]  

  • 16. How would China achieve WHO's target of eliminating HCV by 2030?
    Li M; Zhuang H; Wei L
    Expert Rev Anti Infect Ther; 2019 Oct; 17(10):763-773. PubMed ID: 31578079
    [No Abstract]   [Full Text] [Related]  

  • 17. What is required for achieving hepatitis C virus elimination in Singapore? A modeling study.
    Chaillon A; Thurairajah PH; Hsiang JC; Martin NK
    J Gastroenterol Hepatol; 2021 Apr; 36(4):1110-1117. PubMed ID: 32777859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
    Jonas MC; Loftus B; Horberg MA
    Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination?
    Kondili LA; Blach S; Razavi H; Craxì A
    Ann Ist Super Sanita; 2020; 56(3):325-329. PubMed ID: 32959798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH).
    Crespo J; Albillos A; Buti M; Calleja JL; García-Samaniego J; Hernández-Guerra M; Serrano T; Turnes J; Acín E; Berenguer J; Berenguer M; Colom J; Fernández I; Fernández Rodríguez C; Forns X; García F; Rafael Granados ; Lazarus JV; Molero JM; Molina E; Pérez Escanilla F; Pineda JA; Rodríguez M; Romero M; Roncero C; Saiz de la Hoya P; Sánchez Antolín G
    Gastroenterol Hepatol; 2019 Nov; 42(9):579-592. PubMed ID: 31594683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.